Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Flaherty

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Journal of Cancer Research and Clinical Oncology|June 8, 1999
Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trialK A Margolin, P Y Liu, J M Unger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the Southwest Oncology GroupVernon K Sondak, P-Y Liu, Ralph J Tuthill, et al.
BMJ Paediatrics Open|January 8, 2024
Development and evaluation of a clinical guideline for a paediatric telemedicine service in a low-resource settingMolly B Klarman, Xiaofei Chi, Youseline Cajusma, et al.
Journal for Immunotherapy of Cancer|July 29, 2018
A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanomaJoseph I Clark, Jatinder Singh, Marc S Ernstoff, et al.
Tropical Medicine & International Health : TM & IH|January 16, 2025
Applying the ADAPT guidance to implement a telemedicine and medication delivery service in a malaria-endemic setting: A prospective cohort studyKatelyn E Flaherty, Mohammed-Najeeb Mahama, Molly B Klarman, et al.
The Journal of Pediatrics|December 17, 2022
Implementation of a Pediatric Telemedicine and Medication Delivery Service in a Resource-limited Setting: A Pilot Study for Clinical Safety and FeasibilityMolly B Klarman, Katelyn E Flaherty, Xiaofei Chi, et al.
The Journal of Infectious Diseases|November 17, 1998
Transmission of Chlamydia trachomatis and Neisseria gonorrhoeae among men with urethritis and their female sex partnersJ S Lin, S P Donegan, T C Heeren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2014
Southwest Oncology Group S0008: a phase III trial of high-dose interferon Alfa-2b versus cisplatin, vinblastine, and dacarbazine, plus interleukin-2 and interferon in patients with high-risk melanoma--an intergroup study of cancer and leukemia Group B, Children's Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology GroupLawrence E Flaherty, Megan Othus, Michael B Atkins, et al.
Frontiers in Public Health|March 27, 2023
The infected and the affected: A longitudinal study of the impact of the COVID-19 pandemic on schoolchildren in FloridaSarah L McKune, Daniel Acosta, Yui Fujii, et al.
The American Journal of Clinical Nutrition|July 21, 2020
Strengthening national nutrition research: rationale and options for a new coordinated federal research effort and authoritySheila E Fleischhacker, Catherine E Woteki, Paul M Coates, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Journal of Cancer Research and Clinical Oncology|June 8, 1999
Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trialK A Margolin, P Y Liu, J M Unger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the Southwest Oncology GroupVernon K Sondak, P-Y Liu, Ralph J Tuthill, et al.
BMJ Paediatrics Open|January 8, 2024
Development and evaluation of a clinical guideline for a paediatric telemedicine service in a low-resource settingMolly B Klarman, Xiaofei Chi, Youseline Cajusma, et al.
Journal for Immunotherapy of Cancer|July 29, 2018
A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanomaJoseph I Clark, Jatinder Singh, Marc S Ernstoff, et al.
Tropical Medicine & International Health : TM & IH|January 16, 2025
Applying the ADAPT guidance to implement a telemedicine and medication delivery service in a malaria-endemic setting: A prospective cohort studyKatelyn E Flaherty, Mohammed-Najeeb Mahama, Molly B Klarman, et al.
The Journal of Pediatrics|December 17, 2022
Implementation of a Pediatric Telemedicine and Medication Delivery Service in a Resource-limited Setting: A Pilot Study for Clinical Safety and FeasibilityMolly B Klarman, Katelyn E Flaherty, Xiaofei Chi, et al.
The Journal of Infectious Diseases|November 17, 1998
Transmission of Chlamydia trachomatis and Neisseria gonorrhoeae among men with urethritis and their female sex partnersJ S Lin, S P Donegan, T C Heeren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2014
Southwest Oncology Group S0008: a phase III trial of high-dose interferon Alfa-2b versus cisplatin, vinblastine, and dacarbazine, plus interleukin-2 and interferon in patients with high-risk melanoma--an intergroup study of cancer and leukemia Group B, Children's Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology GroupLawrence E Flaherty, Megan Othus, Michael B Atkins, et al.
Frontiers in Public Health|March 27, 2023
The infected and the affected: A longitudinal study of the impact of the COVID-19 pandemic on schoolchildren in FloridaSarah L McKune, Daniel Acosta, Yui Fujii, et al.
The American Journal of Clinical Nutrition|July 21, 2020
Strengthening national nutrition research: rationale and options for a new coordinated federal research effort and authoritySheila E Fleischhacker, Catherine E Woteki, Paul M Coates, et al.
Pageof 13